Literature DB >> 4009431

Conformational polymorphism VI: the crystal and molecular structures of form II, form III, and form V of 4-amino-N-2-pyridinylbenzenesulfonamide (sulfapyridine).

I Bar, J Bernstein.   

Abstract

The crystal structures of three crystalline forms of 4-amino-N-pyridinylbenzenesulfonamide (sulfapyridine) have been determined by X-ray single crystal structure analysis. Form II crystallizes in space group P2(1)/c with four molecules in the unit cell: a = 0.6722(1) nm, b = 2.0593(5) nm, c = 0.8505(1) nm, beta = 101.14(1) degrees; Form III crystallizes in space group C2/c with eight molecules in the unit cell: a = 1.2830(2) nm, b = 1.1714(3) nm, c = 1.5400(3) nm, beta = 94.12(1) degrees; Form V crystallizes in the orthorhombic space group Pbca with 16 molecules in the unit cell: a = 2.4722(10) nm, b = 1.5710(15) nm, c = 1.2147(7) nm. The three structures were solved by direct methods and refined anisotropically to R factors of 0.045, 0.052, and 0.063, respectively. Bond lengths and bond angles agree well among the molecules in these structures; however, the system exhibits conformational polymorphism since the molecular conformation, as measured by torsion angles, differs significantly among the three forms. Sulfapyridine exhibits the imide configuration in all three structures rather than the amide form present in other sulfonamide compounds. Using the structural data, the powder patterns of the three forms have been computer generated to provide standard diffraction patterns for comparison with the variety of polymorphic forms reported in the literature.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4009431     DOI: 10.1002/jps.2600740307

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  Sulfapyridine (polymorph III), sulfapyridine dioxane solvate, sulfapyridine tetrahydrofuran solvate and sulfapyridine piperidine solvate, all at 173 K.

Authors:  Jamal Pratt; Janna Hutchinson; Cheryl L Klein Stevens
Journal:  Acta Crystallogr C       Date:  2011-11-05       Impact factor: 1.172

2.  Monitoring model drug microencapsulation in PLGA scaffolds using X-ray powder diffraction.

Authors:  Adeyinka Aina; Manish Gupta; Yamina Boukari; Andrew Morris; Nashiru Billa; Stephen Doughty
Journal:  Saudi Pharm J       Date:  2015-03-21       Impact factor: 4.330

3.  Molecular conformational evolution mechanism during nucleation of crystals in solution.

Authors:  Xin Li; Na Wang; Jinyue Yang; Yunhai Huang; Xiongtao Ji; Xin Huang; Ting Wang; Honghai Wang; Hongxun Hao
Journal:  IUCrJ       Date:  2020-04-24       Impact factor: 4.769

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.